CheckMan Stock Market Overview

Valneva (VALN) is transitioning from a low-margin vaccine manufacturer to a high-margin royalty and milestone model, anchored by its Lyme disease partnership with Pfizer. Recent financials were impacted by IXCHIQ-related charges, but restructuring is improving the expense base and cash runway, with about three years of funding at current burn rates. Pfizer's Lyme vaccine candidate, with 73% efficacy and EMA validation, positions VALN for significant royalty and milestone income if approved and successfully commercialized.

ProShares Ultra Silver ETF (AGQ) is rated a Buy, but only as a short-term trading tool, not a long-term investment. AGQ's leverage amplifies silver's volatility, requiring disciplined risk-reward management, stop-loss planning, and profit-taking strategies. Silver's bullish trend is intact, supported by a persistent supply-demand deficit and technical support above the 1980 high of $50.36/oz.

BABA is selling Lingxi Games as it doubles down on AI and cloud, but stretched valuation and intense competition leave investors weighing whether to hold.

New York, New York--(Newsfile Corp. - August 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between December 17, 2025 and July 26, 2026, inclusive (the "Class Period"), of the important September 28, 2026 lead plaintiff deadline. SO WHAT: If you purchased Capricor securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cullen/Frost (CFR) have what it takes?

Altria (NYSE: MO | MO Price Prediction) shares, which have one of the best dividend performances in the S&P 500, have tracked the market this year.

New York, New York--(Newsfile Corp. - August 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cogent Communications Holdings, Inc. (NASDAQ: CCOI) between February 29, 2024 and May 1, 2026, inclusive (the "Class Period"), of the important September 21, 2026 lead plaintiff deadline. SO WHAT: If you purchased Cogent Communications common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Between August 13 and 14, 2026, Q2 2026 13F filings landed and told a rare story: Stanley Druckenmiller, Seth Klarman, David Tepper, Dan Loeb, and Berkshire Hathaway all moved into Alphabet (NASDAQ:GOOGL | GOOGL Price Prediction) in the same quarter.

New York, New York--(Newsfile Corp. - August 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Avis Budget Group, Inc. (NASDAQ: CAR), including those who bought Avis common stock to cover a short position, between February 20, 2025 and April 21, 2026, inclusive (the "Class Period"), of the important September 29, 2026 lead plaintiff deadline. SO WHAT: If you purchased Avis securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NTRA is using its Latitude MRD test in Kupando's Phase 1 skin cancer trial to track ctDNA and characterize response to KUP-101.